Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

  • This share is currently suspended. It was suspended at a price of 0.25
  • There is currently no data for TLY

Warrant Placing

5 Dec 2012 11:01

5 December 2012 AIM: TLY Totally Plc ("Totally", "the Group" or "the Company") Warrant Placing

Totally Plc announces that it has today entered into a vendor placing agreement (the "Agreement"), whereby certain existing warrant holders have agreed to sell 113,676,6 81 warrants to subscribe for 113,676,6 81 new ordinary shares of 1p each in the Company (the "Warrants") to investors (the "Investors") procured by Optiva Securities Limited ("Optiva") at a purchase price of 0.2p per warrant.

Under the terms of the Agreement, Optiva will procure that the Investors exercise 56,838,341 of the Warrants to subscribe for 56,838,341 ordinary shares of 1p each on or before 3.00 p.m. on 14 December 2012 (or such later date as Optiva and the Company shall agree) (the "First Subscription") and 56,838,340 of the Warrants to subscribe for 56,838,34 0 ordinary shares of 1p each on or before 3.00 p.m. on 14 January 2013 (or such later date as Optiva and the Company shall agree) (the "Second Subscription"), (the "Vendor Placing"), at an exercise price of 1p per share. The Warrant holders include certain members of the board of directors (the "Vendors") (further details of which are given below).

As a result of the Vendor Placing the Company will raise just over £1.1m before expenses and simplify its capital structure.

Following completion of the Vendor Placing, 35,000,000 of the existing 148,676,6 81 warrants exercisable at 1p will remain outstanding, exercisable until 30 September 2013 together with 4,702,318 warrants exercisable at 2.88p until 10 April 2017. In accordance with the terms of the Agreement, Optiva will be granted 5,683,834 new warrants to subscribe for 5,683,834 new ordinary shares of 1p each in the Company, exercisable for a period of three years from the date of grant at a price of 1.2p per share, conditional upon completion of purchase of the Warrants and completion of both the First Subscription and the Second Subscription.

The Vendors and their respective Warrant holdings are as follows:

Date of Issue No. of Warrants Exercise Price (GBp) Dan Assor* 27 July 2009 9,080,633 1 Dan Assor* 13 April 2010 32,424,1 43 1 Benjamin Gritz** 22 April 2010 7,500,000 1 Grand Rabbi Y.A. Korff^ 2 July 2008 4,500,000 1 Andy Margolis* 27 July 2009 7,671,905 1 Andy Margolis* 22 April 2010 17,500,000 1 Michael Sinclair* 30 September 2008 35,000,000 1 113,367,6 81 * Director of Totally** Senior management of Totally

^ The exercise price of Grand Rabbi Y.A. Korff's warrant was amended, with the agreement of all warrant holders, from 1.25p to 1p.

The Vendor Placing constitutes a related party transaction within the meaning of the AIM Rules and accordingly the independent directors, being Clare Wexler and Don Baladasan for this purpose, having consulted with the Company's Nominated Adviser, Merchant Securities Limited, consider that the terms of the Vendor Placing are fair and reasonable insofar as the Shareholders are concerned.

Commenting on the Vendor Placing, Clare Wexler, Chief Executive Officer of Totally Plc, said:

"We are delighted that Optiva Securities has put together the warrant deal which allows us to rationalise the share structure of the Company and to provide working capital to deliver the new business strategy going forward."

For further information please contact:

Totally Plc T: 020 7284 9730Clare Wexler Chief Executive Officer Merchant Securities Limited (Nomad) T: 020 7628 2200Lindsay Mair/Richard Goldsmith Optiva Securities Limited (Broker) T: 020 3137 1902

Jeremy king

XLON
Date   Source Headline
7th Jul 20257:00 amRNSCancellation - Totally Plc
9th Jun 20257:00 amRNSAdministration and Director Resignations
6th Jun 20251:00 pmRNSIntention to Appoint Administrators and Suspension
6th Jun 20251:00 pmRNSSuspension - Totally plc
30th May 20252:25 pmRNSHolding(s) in Company
29th May 20252:10 pmRNSHolding(s) in Company
23rd May 20257:00 amRNSUpdate on Strategic Review
2nd May 20257:00 amRNSHolding(s) in Company
1st May 20257:00 amRNSCommencement of Strategic Review
1st May 20257:00 amRNSTrading Update
27th Mar 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20253:35 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Mar 20253:15 pmRNSHolding(s) in Company
3rd Mar 20259:00 amRNSHolding(s) in Company
3rd Mar 20259:00 amRNSHolding(s) in Company
28th Feb 20257:00 amRNSHolding(s) in Company
27th Feb 20257:00 amRNSContract Renewals
26th Feb 20251:00 pmRNSHolding(s) in Company
25th Feb 20256:00 pmRNSHolding(s) in Company
25th Feb 202511:00 amRNSHolding(s) in Company
21st Feb 20257:00 amRNSDirectorate Change
20th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20257:00 amRNSOutlook Update
13th Jan 20257:00 amRNSDirectorate Change
7th Jan 20254:15 pmRNSHolding(s) in Company
3rd Dec 20244:00 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSInterim Results
5th Nov 20245:00 pmRNSHolding(s) in Company
31st Oct 20247:00 amRNSUpdate on Banking Facility
17th Oct 20247:00 amRNSNotice of Interim Results & Investor Presentation
27th Sep 20245:45 pmRNSResult of AGM
27th Sep 20249:00 amRNSAGM Statement
27th Sep 20247:00 amRNSContract Win and Extension
20th Sep 20242:30 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSDirector/PDMR Shareholding
4th Sep 20241:30 pmRNSPosting of Annual Report and Notice of AGM
4th Sep 20247:00 amRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSContract Wins
27th Aug 20246:16 pmRNSHolding(s) in Company
27th Aug 20246:13 pmRNSHolding(s) in Company
2nd Aug 20249:30 amRNSHolding(s) in Company
2nd Aug 20247:00 amRNSDirectorate Change
1st Aug 202410:45 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSDirectorate Change
24th Jul 20247:00 amRNSPreliminary results
23rd Jul 20247:00 amRNSContract extensions and win
22nd Jul 20243:30 pmRNSHolding(s) in Company
18th Jul 20247:00 amRNSNotice of Results
11th Jul 20247:00 amRNSContract extensions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.